GRAIL
GRAIL is a healthcare company, pioneering new technologies to advance early cancer detection. We have built a multi-disciplinary organization of scientists, engineers, and physicians and we are using the power of next-generation sequencing (NGS), population-scale clinical studies, and state-of-the-art computer science and data science to overcome one of medicine’s greatest challenges. GRAIL’s methylation solution is uniquely suited for the detection, quantification, and classification of cancer through a non-invasive blood draw.Â
Our mission is to detect cancer early when it can be cured. We are working to change the trajectory of cancer mortality and bring stakeholders together to adopt innovative, safe and effective technologies that can transform cancer screening and advance novel cancer therapeutics.Â
